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I read with great interest the recent paper of Gordeuk
et al.1 on congenital polycythemias/erythrocytoses, in
which a diagnostic algorithm based on serum erythropoi-
etin (Epo) concentration in non-phlebotomized patients
is presented. As a first step the authors propose classifica-
tion into primary erythrocytosis (increased red cell mass
due to intrinsically abnormal bone marrow erythro-
poiesis) versus secondary erythrocytosis (excessive ery-
throid proliferation in response to pathological events
outside the progenitor cells) according to whether the
serum Epo level is below or above 5 IU/L. 
Primary erythrocytoses are further distinguished into
primary familial and congenital polycythemia (PFCP) and
polycythemia vera (PV), the latter being acquired but
occasionally occurring in a familial or juvenile context,
whereas secondary congenital polycythemias can be sub-
divided into disorders of hypoxia sensing, conditions of
increased affinity of hemoglobin for oxygen (hemoglobin
mutants, 2,3-bisphosphoglycerate deficiency, methemo-
globinemia) and congenital cyanotic heart or lung dis-
ease. The use of a unique clear-cut serum Epo level as
classification criterion for primary versus secondary ery-
throcytosis, however, does not correspond to observa-
tions in a number of studies evaluating the discriminating
value of serum Epo levels in polycythemic patients. Low
serum Epo values have high specificity and moderate sen-
sitivity for diagnosis of primary polycythemia compared
with other erythrocytoses (Table 1). 
Table. Studies evaluating the sensitivity and specificity of low
serum Epo values for diagnosis of primary erythrocytosis in poly-
cythemic subjects.*
Diagnostic Diagnostic ntot° nPE$
sensitivity (%) specificity (%)
Available data for untreated polycythemic patients (at initial diagnosis)
Mossuz et al.2 89 97 162 99
Shih et al.3 53 92 110 47
Remacha et al.4 60 99 190 43
Birgegard and Wide5 94 97 67 36
Available data for unselected (treated and untreated) polycythemic patients
Messinezy et al.6 64 92 125 42
Messinezy et al.7 64 / 72§ 99 130 42 / 36§
*Only studies after 1990 are included because of limited accuracy and repro-
ducibility of early Epo assays. °ntot: total number of polycythemic patients in
study. $nPE: number of patients with primary erythrocytosis in study. §A single
serum Epo estimation resulted in a low Epo level in 64% (27/42) of PV patients.
When two samples were taken on different occasions, 72% (26/36) of PV patients
had at least one low serum Epo value.
A normal serum Epo concentration does not exclude
the possibility of PV2-7 nor PFCP8, and even slightly raised
Epo values have been observed in PV.3 High serum Epo
levels are most suggestive for secondary erythrocytosis
but also occur in a significant proportion of patients with
idiopathic erythrocytosis (increased red cell mass of
unknown etiology after appropriate investigation) and
apparent or relative erythrocytosis (raised packed cell vol-
ume but red cell mass within the normal range).3,6,7
Despite considerable improvement in accuracy and preci-
sion of Epo assays, there remains an important overlap in
serum Epo levels between primary and secondary ery-
throcytosis.2-4,6,7 Thus, although a low serum Epo concen-
tration is indicative of primary erythrocytosis and an ele-
vated Epo level suggests tissue hypoxia, deregulated
hypoxia sensing or autonomous Epo production, a nor-
mal serum Epo value is not discriminatory towards the
origin of an absolute erythrocytosis. Serum Epo thresh-
olds with a 100% predictive value for the diagnosis or
exclusion of PV and secondary erythrocytosis were
recently defined in a large multi-center study.2 Serum cut-
off values of 1.4 IU/L and 13.7 IU/L, determined with a
commercial ELISA kit, allowed specific and direct diagno-
sis of 65.6% of untreated PV subjects (Epo < 1.4 IU/L)
and 19.7% of patients with secondary erythrocytosis
(Epo > 13.7 IU/L). More than half of the patients howev-
er displayed serum Epo levels between these two thresh-
olds and could thus not be classified on the basis of serum
Epo estimation alone.
As serum Epo values are known to be inversely related
to hemoglobin (Hb) levels in normal individuals, it is
important to consider the discriminating value of Epo lev-
els in erythrocytosis in light of the Hb concentration. This
relationship was investigated by Messinezy et al. in a
series of 125 unselected, treated and untreated poly-
cythemic patients.6 The specificity of high Epo values for
secondary erythrocytosis appeared to be less when the
Hb concentration was not raised (< 16 g/dL), while low
Epo values were less specific for PV at higher Hb levels (>
16 g/dL). The latter is in accordance with previous obser-
vations that after phlebotomy treatment to normal hema-
tocrit levels, serum Epo levels increase in secondary ery-
throcytosis but remain usually low in PV.3-5 The tentative
diagnosis of primary erythrocytosis in case of a low
serum Epo value at presentation should therefore be con-
firmed by redetermination of the serum Epo concentra-
tion after treatment.6,9
In conclusion, serum Epo measurement is mainly help-
ful for diagnosis of primary erythrocytosis but does not
provide an absolute classification criterion for the major-
ity of polycythemic individuals. Diagnostic evaluation of
an absolute erythrocytosis should comprise a number of
key investigations in all patients.10 Additional tests can
then be selected in a second stage to further clarify the
cause of erythrocytosis. For the specific group of congen-
ital polycythemias, which shows a much more restricted
range of possible diagnoses than erythrocytoses in gener-
al, a rational and simplified work-up scheme has been
recently proposed.9
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